G1 Therapeutics, Inc. short interest in 2021
In 2021, G1 Therapeutics, Inc.'s disclosed short interest ran from 15.85% of shares outstanding on 15 Jan 2021 to 21.18% on 31 Dec 2021, a change of +5.33 percentage points. The year's high was 21.85% on 15 Dec 2021 and its low 13.71% on 12 Feb 2021, averaging 17.75% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.40 days on 31 Dec 2021. Full history: G1 Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2021 in figures
- Start of year
- 15.85% (15 Jan 2021)
- End of year
- 21.18% (31 Dec 2021)
- Change
- +5.33 pp
- High
- 21.85% (15 Dec 2021)
- Low
- 13.71% (12 Feb 2021)
- Average
- 17.75%
- Highest days to cover
- 11.40 (31 Dec 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 15.85% | 5.72 | results (8-K) |
| 29 Jan 2021 | 14.14% | 5.19 | |
| 12 Feb 2021 | 13.71% | 3.45 | |
| 26 Feb 2021 | 16.64% | 2.29 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 20.13% | 5.28 | |
| 31 Mar 2021 | 19.55% | 7.12 | |
| 15 Apr 2021 | 18.30% | 7.55 | |
| 30 Apr 2021 | 16.75% | 10.99 | |
| 14 May 2021 | 15.28% | 6.34 | 10-Q filed, results (8-K) |
| 28 May 2021 | 14.94% | 10.46 | |
| 15 Jun 2021 | 14.25% | 4.83 | |
| 30 Jun 2021 | 13.86% | 5.58 | |
| 15 Jul 2021 | 14.55% | 4.05 | |
| 30 Jul 2021 | 17.36% | 5.77 | |
| 13 Aug 2021 | 17.81% | 9.49 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 18.01% | 8.69 | |
| 15 Sep 2021 | 17.36% | 10.72 | |
| 30 Sep 2021 | 21.30% | 8.42 | |
| 15 Oct 2021 | 19.94% | 9.20 | |
| 29 Oct 2021 | 20.89% | 9.17 | |
| 15 Nov 2021 | 21.07% | 9.33 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 21.24% | 10.61 | |
| 15 Dec 2021 | 21.85% | 8.69 | |
| 31 Dec 2021 | 21.18% | 11.40 |
See also: G1 Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.